Value-based pricing hot at ISPOR

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.642, 2011-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK's proposed value-based pricing under the spotlight

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

UK Office of Fair Trading wants value-based pricing of drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 527, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The UK government wants to implement a value-based pricing system for drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 535, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Bortezomib: one step closer to value-based pricing?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 533, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Denosumab's value deduced at ISPOR

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite